NT5E and melanoma: Alternatively, strategies that interfere with the CD73 ectonucleotidase on melanoma cells have already been shown to improve antitumor immunity in preclinical models (169, 181), and this outcome is likely due to a reduction in the immunoregulatory effects of adenosine on multiple immune cell populations, including DC.